With the onset of summer, shares of Adani Energy Solutions have attracted strong investor interest, rallying over 63% in just three months....

Paytm shares fell 8% after RBI cancelled Paytm Payments Bank’s licence but recovered sharply as brokerages stayed bullish. Analysts see lim...

India and New Zealand will sign a Free Trade Agreement on Monday, April 27. This landmark deal aims to boost bilateral trade significantly....

The EMA's review of Merck's pill, developed with Ridgeback Biotherapeutics, is taking longer than Pfizer's because Merck released trial dat...

The EU regulator said on September 6 it had begun its evaluation of data submitted by Pfizer and BioNTech for a booster dose to be given si...

Separately, an assessment of Sputnik V by a French delegation of scientists in advance of the EMA review found that the vaccine developers ...

The European Medicines Agency (EMA) said in a statement that it had found a "possible link" between the jab and the clots, following eight ...

No specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune res...

The EMA is the regulator for all human and animal medicines in the 27 nations of the European Union plus the European Economic Area countri...

The Amsterdam-based European drug regulator in December reported a cyberattack in which documents relating to COVID-19 vaccines and medicin...

In a statement on Tuesday, the Amsterdam-based medicines regulator for the European Union said it could issue an opinion by the middle of M...

The facility, set up with an investment of $275 million, is designed to manufacture recombinant human insulin and insulin analogs for the g...

Lupin said that company has successfully conducted the new bio equivalence (BE) studies for the said products and submitted the report to E...

The German watchdog said it will take a decision shortly on whether to add more medicines to the list of banned drugs in the wake of the EM...

European Medicines Agency (EMA) said in a statement that it is reviewing findings of non-compliance with good clinical practise at the GVK ...

The assessment of the Toansa facility by EMA followed an inspection by the USFDA, which revealed areas of non-compliance with GMP at the si...

Exports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, European health regulator EMA sai...